Sheeba M. | Weedstock Market Intelligence | Wednesday, September 23, 2026 — 1:20 PM ET
Verano Holdings (OTC: VRNOF) is holding midday Wednesday in the $5.80–$6.10 range as institutional attention remains fixed on the operator’s multi-state footprint and its leverage into the DEA Schedule III rescheduling timeline. With the DEA public comment period now firmly in the rearview and implementation pathways narrowing toward an October window, Verano’s 280E tax exposure story is one of the cleanest in the sector.
Illinois and Florida: Verano’s Anchor Markets Hold Firm
Verano’s Illinois operations continue to generate best-in-class revenue per dispensary, benefiting from the state’s mature adult-use market and Verano’s premium brand positioning through Zen Leaf and MUV. Wednesday’s midday tape shows no material distribution pressure in VRNOF, which market participants interpret as institutional holders maintaining conviction ahead of Q3 earnings.
Florida remains a critical swing factor. Verano operates 66 MUV dispensaries across the Sunshine State, and with Amendment 3’s adult-use legalization still pending regulatory implementation, any forward guidance on Florida ramp timing will be closely scrutinized by analysts. The midday read on VRNOF suggests the market is pricing in a patient hold — not a run — ahead of that catalyst.
280E Schedule III Leverage: The Earnings Multiple Story
For Verano specifically, the 280E reclassification math is compelling. At current revenue run rates, analysts modeling Schedule III impact estimate $30–$45M in annualized tax savings for Verano — a figure that would flow directly to operating cash flow and dramatically improve net income comparables. This is the core reason VRNOF has outperformed peers like CURLF and GTBIF on a relative basis since mid-summer.
Verano’s management team has been disciplined about not front-running the savings in forward guidance — a conservative posture that sets up a potential positive surprise when Q3 numbers drop. The company has guided to Q3 revenue in the $215–$225M range; beat scenarios look achievable given strong summer retail performance in Illinois and New Jersey.
Q3 2026 Earnings Setup: October Catalyst Window
Verano’s Q3 2026 earnings are expected in early-to-mid November, but the pre-earnings positioning window opens in October as institutional research desks begin circulating preview notes. Wednesday’s midday tape in VRNOF at roughly 3.2x average daily volume suggests systematic accumulation — not retail noise.
Key metrics to watch into the print:
- Adjusted EBITDA margin: Verano targets 30%+ — any beat here moves the stock
- Same-store sales growth: Illinois comps likely flat-to-slightly-positive; Florida the wildcard
- Cash flow from operations: Post-280E-relief modeling makes this the headline number
- CapEx discipline: Management has signaled limited new-build spending; investors want FCF inflection
Peer Comparison: Where VRNOF Sits in the MSO Stack
Against the broader MSO peer group on Wednesday, Verano’s risk/reward profile remains attractive at current multiples. CURLF carries more restructuring execution risk; GTBIF trades at a premium on quality; TCNNF is a Florida pure-play with higher optionality but lower certainty. Verano threads the needle — diversified enough to absorb state-level volatility, concentrated enough to move materially on Florida legalization.
TLRY and OGI remain the LP bellwethers for Schedule III optics in Canadian cross-border scenarios, but for domestic MSO exposure into Q3 earnings season, VRNOF’s Wednesday midday tape reads as controlled accumulation.
TL;DR
Verano Holdings (VRNOF) is trading constructively into Wednesday afternoon with above-average volume suggesting institutional accumulation. The 280E/Schedule III tax relief thesis is intact and the Q3 earnings setup in October/November looks favorable. Illinois and Florida market positions anchor the bull case; Florida adult-use timing is the primary swing variable. Watch the $6.20 level for breakout confirmation.